These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28936810)

  • 1. Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.
    Weixler B; Renetseder F; Facile I; Tosti N; Cremonesi E; Tampakis A; Delko T; Eppenberger-Castori S; Tzankov A; Iezzi G; Kettelhack C; Soysal SD; von Holzen U; Spagnoli GC; Terracciano L; Tornillo L; Droeser RA; Däster S
    Cell Oncol (Dordr); 2017 Dec; 40(6):609-619. PubMed ID: 28936810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.
    Walther F; Berther JL; Lalos A; Ramser M; Eichelberger S; Mechera R; Soysal S; Muenst S; Posabella A; Güth U; Stadlmann S; Terracciano L; Droeser RA; Zeindler J; Singer G
    BMC Cancer; 2022 Apr; 22(1):376. PubMed ID: 35397601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia.
    Konoplev S; Lin P; Yin CC; Lin E; Nogueras González GM; Kantarjian HM; Andreeff M; Medeiros LJ; Konopleva M
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):686-92. PubMed ID: 24035716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia.
    Konoplev S; Jorgensen JL; Thomas DA; Lin E; Burger J; Kantarjian HM; Andreeff M; Medeiros LJ; Konopleva M
    Cancer; 2011 Oct; 117(20):4689-95. PubMed ID: 21456010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
    Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
    Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
    Lalos A; Tülek A; Tosti N; Mechera R; Wilhelm A; Soysal S; Daester S; Kancherla V; Weixler B; Spagnoli GC; Eppenberger-Castori S; Terracciano L; Piscuoglio S; von Flüe M; Posabella A; Droeser RA
    Sci Rep; 2021 Jan; 11(1):775. PubMed ID: 33436863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of CXCR4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density.
    Wilhelm A; Lemmenmeier I; Lalos A; Posabella A; Kancherla V; Piscuoglio S; Delko T; von Flüe M; Glatz K; Droeser RA
    BMC Endocr Disord; 2022 Nov; 22(1):292. PubMed ID: 36419107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung.
    Sterlacci W; Saker S; Huber B; Fiegl M; Tzankov A
    Virchows Arch; 2016 Apr; 468(4):463-71. PubMed ID: 26818832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
    Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
    Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer.
    Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H
    Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
    Kim J; Mori T; Chen SL; Amersi FF; Martinez SR; Kuo C; Turner RR; Ye X; Bilchik AJ; Morton DL; Hoon DS
    Ann Surg; 2006 Jul; 244(1):113-20. PubMed ID: 16794396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer.
    Xu C; Zheng L; Li D; Chen G; Gu J; Chen J; Yao Q
    Life Sci; 2018 Sep; 208():333-340. PubMed ID: 29719205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
    Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vascular CXCR4 expression in colorectal carcinoma.
    Ingold B; Schulz S; Budczies J; Neumann U; Ebert MP; Weichert W; Röcken C
    Histopathology; 2009 Nov; 55(5):576-86. PubMed ID: 19912363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways.
    Zheng F; Zhang Z; Flamini V; Jiang WG; Cui Y
    Anticancer Res; 2017 Aug; 37(8):4361-4369. PubMed ID: 28739729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.